Filing Details

Accession Number:
0001796271-20-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-11 17:28:00
Reporting Period:
2020-08-07
Accepted Time:
2020-08-11 17:28:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656472 Cronos Group Inc. CRON Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796271 Kevin Todd Abraham 111 Peter Street, Suite 300
Toronto A6 M5V 2G9
Chief Innovation Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2020-08-07 15,000 $5.78 15,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.79, inclusive. The reporting person undertakes to provide to Cronos Group Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.